Study of Recombinant Salmon Calcitonin in post menopausal women

• Research type

  Research Study

• Full title

  A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Parallel Group, 48 Week Study of Oral Recombinant sCT Compared to Calcitonin Nasal Spray in Postmenopausal Osteoporotic Women

• IRAS ID

  14606

• Contact name

  John Robinson

• Contact email

  john.robinson@synexus.com

• Sponsor organisation

  Unigene Laboratories, Inc

• Eudract number

  2008-003322-42

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  no contact from researchers although changes previously requested - not published on NRES website. Valerie Heard processed (comment BR 5/04/13)

• REC name

  London - City & East Research Ethics Committee

• REC reference

  09/H0703/7

• Date of REC Opinion

  29 Jul 2009

• REC opinion

  Further Information Favourable Opinion